(Q40023848)

English

SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model

scientific article published on 17 January 2008

Statements

SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model (English)
Michael J Corbley
Jessica E Friedman
James L Papadatos
Frank Lutterodt
P Ann Boriack-Sjodin
Robert M Arduini
Jonathan N Mead
Claudio E Chuaqui
Mark Cornebise
Mary Beth Carter
Juswinder Singh
Wen-Cherng Lee

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit